CCL2 and breast carcinoma: Neutralization of MCP-1 derived from either tumor cells or stromal cells blocked the recruitment of inflammatory monocytes, inhibited lung metastasis of breast cancer cells and prolonged the survival of tumor-bearing mice [46].